title: Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants.
abstract: In respiratory syncytial virus (RSV) disease the balance between the innate and adaptive immune responses determines the expression of the pathological phenotype favoring the development of acute bronchiolitis, and in certain children the development of recurrent wheezing. While humoral antibody plays a major role in protection against disease, T-cell immunity targeted to viral proteins appears to terminate viral infection. At the moment, treatment modalities for acute RSV infection do not effectively modify the course of the disease, and RSV vaccine development has shown conflicting results. To date, however, passive immunoprophylaxis with monoclonal antibodies is the only strategy that has demonstrated consistent efficacy in reducing RSV hospitalizations in high-risk children. The potential benefit of new strategies for prevention and treatment of RSV infections should be evaluated with respect to both the acute infection as well as the chronic respiratory manifestations induced by RSV.
authors.affiliation: Division of Pediatric Infectious Diseases, The University of Texas, Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA.
authors.forename: Asunción
authors.initials: A
authors.lastname: Mejías
authors.forename: Octavio
authors.initials: O
authors.lastname: Ramilo
references.citation: Virology. 2004 Jan 20;318(2):608-12
references.pmid: 14972528
references.citation: Pediatrics. 2003 Dec;112(6 Pt 1):1442-6
references.pmid: 14654627
references.citation: J Infect Dis. 1997 Nov;176(5):1215-24
references.pmid: 9359721
references.citation: J Infect Dis. 1998 Dec;178(6):1555-61
references.pmid: 9815203
references.citation: Pediatrics. 1998 Sep;102(3):531-7
references.pmid: 9724660
references.citation: Pediatr Infect Dis J. 1999 Oct;18(10):866-9
references.pmid: 10530581
references.citation: J Pediatr. 2003 Oct;143(4):532-40
references.pmid: 14571236
references.citation: N Engl J Med. 1993 Nov 18;329(21):1524-30
references.pmid: 8413475
references.citation: Antimicrob Agents Chemother. 2004 May;48(5):1811-22
references.pmid: 15105140
references.citation: J Infect Dis. 2004 May 15;189(10):1856-65
references.pmid: 15122522
references.citation: Paediatr Respir Rev. 2004;5 Suppl A:S179-84
references.pmid: 14980267
references.citation: J Allergy Clin Immunol. 2004 Jan;113(1):127-33
references.pmid: 14713917
references.citation: J Infect Dis. 2004 Dec 1;190(11):1941-6
references.pmid: 15529258
references.citation: Pediatr Res. 2004 Dec;56(6):914-7
references.pmid: 15470202
references.citation: J Virol. 2004 Apr;78(8):4363-9
references.pmid: 15047850
references.citation: JAMA. 1999 Oct 20;282(15):1440-6
references.pmid: 10535434
references.citation: Treat Respir Med. 2006;5(6):483-94
references.pmid: 17154675
references.citation: Pediatr Pulmonol. 2008 Feb;43(2):169-74
references.pmid: 18085710
references.citation: J Pediatr. 1976 Jul;89(1):11-5
references.pmid: 180274
references.citation: Pediatr Cardiol. 2008 Mar;29(2):382-7
references.pmid: 17926087
references.citation: J Pediatr. 1998 Oct;133(4):492-9
references.pmid: 9787686
references.citation: J Virol. 2004 Aug;78(16):8753-60
references.pmid: 15280483
references.citation: J Infect Dis. 2002 May 1;185(9):1222-8
references.pmid: 12001038
references.citation: J Pediatr. 2007 Jul;151(1):34-42, 42.e1
references.pmid: 17586188
references.citation: Am J Respir Crit Care Med. 2005 Jan 15;171(2):137-41
references.pmid: 15516534
references.citation: J Virol. 1999 Jul;73(7):5852-64
references.pmid: 10364337
references.citation: Pediatr Infect Dis J. 1998 Sep;17(9):787-91
references.pmid: 9779762
references.citation: N Engl J Med. 1984 Dec 27;311(26):1653-8
references.pmid: 6504106
references.citation: Pediatrics. 1997 Jan;99(1):93-9
references.pmid: 8989345
references.citation: Pediatr Pulmonol. 2003 Jun;35(6):484-9
references.pmid: 12746948
references.citation: Am J Dis Child. 1986 Jun;140(6):543-6
references.pmid: 3706232
references.citation: J Pediatr. 2007 Sep;151(3):266-70, 270.e1
references.pmid: 17719935
references.citation: J Virol. 1989 Jul;63(7):2941-50
references.pmid: 2470922
references.citation: Ann Intern Med. 1978 Feb;88(2):203-5
references.pmid: 415653
references.citation: Lancet. 1999 Aug 14;354(9178):541-5
references.pmid: 10470697
references.citation: Antimicrob Agents Chemother. 2005 Nov;49(11):4700-7
references.pmid: 16251314
references.citation: J Infect Dis. 2004 Sep 1;190(5):975-8
references.pmid: 15295704